Caracterização das subpopulações de células mononucleares dos granulomas centrais de células gigantes dos maxilares
Ano de defesa: | 2022 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | |
Tipo de documento: | Dissertação |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Federal de Minas Gerais
Brasil FAO - FACULDADE DE ODONTOLOGIA Programa de Pós-Graduação em Odontologia UFMG |
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: | |
Link de acesso: | http://hdl.handle.net/1843/45689 https://orcid.org/0000-0002-2498-3449 |
Resumo: | Central giant cell granuloma (CGCG) of the jaws is a benign intraosseous lesion, which may present an aggressive course. Seventy per cent of these lesions present mutations in TRPV4, KRAS or FGFR1. The population of mononuclear cells seems to be the proliferative component of the lesion. This mononuclear cell population is a mixed population, composed of both mononuclear cells of monocytic origin and undifferentiated mesenchymal cells. Thus, this study evaluated whether, when placed in culture, the proliferative component of (CGCG) is composed of mesenchymal cells or monocytic cells. The culture of primary CGCG cells was established from a convenience sample composed of a lineage originated from a mandibular lesion in 20 y.o. male patient. The samples were incubated with CD14 and CD51/CD61 antibodies, and triplicate samples were submitted to flow cytometry to identify the subpopulations of cells. It was observed that only mononuclear cells remained along the passages. By flow cytometry, a predominance of triple negative CD14-CD51-CD61- cells was observed, compatible with the expected profile for stromal/mesenchymal cells. Our results reinforce the idea that the mesenchymal cells (CD14-CD51-CD61- ) have central importance in the CGCG pathogenesis, while the mononuclear cells of monocytic origin (CD14+) and the osteoclast-like giant cells (CD51+CD61+) are reactive. |